Prophylactic epicardial pacemaker implantation in tricuspid valve replacement
European Journal of Cardio-Thoracic Surgery · 2023
DOI: 10.1093/ejcts/ezad344 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2023. Verfasst von Baptiste Bazire und 7 weiteren Autor:innen. Beteiligte Einrichtung: Service de Cardiologie, Hôpital Bichat Claude Bernard, AP-HP, Paris, France. Hauptthemen laut MEDLINE: Cardiac Pacing, Artificial, Pacemaker, Artificial. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES Patients undergoing surgical tricuspid valve replacement (TVR) are at high risk of atrioventricular conduction disorders. Because implanting a lead through the tricuspid bioprosthesis is discouraged, the patients who undergo TVR in our centre are usually given a prophylactic epicardial pacemaker. Our aim was to assess the benefits and risks of this strategy. METHODS Among the patients who underwent TVR with prophylactic epicardial pacemaker implantation, clinical evaluations and pacemaker reports were analysed retrospectively after surgery. The need for cardiac pacing were assessed by characterizing the atrioventricular conduction, while the risks were evaluated by listing and adjudicating post-operative events. RESULTS A total of 80 patients were analysed (mean age was 57 ± 16 years old, 30% males). TVR was isolated in 28 (35%) patients, but most often associated with another valve surgery. In the postoperative period, heart rhythm was analysed in 59/80 patients during a median follow-up of 35 months. Cardiac pacing was needed in 46% patients: 14% had complete pacing dependency, 17% had high degree AV block, while 15% had a high ventricular pacing rate (>80%). No pre- or per-operative variables could predict cardiac pacing requirement. Post-operatively, a spontaneous heart rate >70 bpm (P = 0.02) and the presence of narrow QRS (P = 0.03) were significantly associated with a lower risk of cardiac pacing requirement. Complications related to epicardial pacemaker were documented in 2 (2.5%) patients. CONCLUSIONS After TVR, cardiac pacing was needed in 46% of patients for post-operative atrioventricular conduction disorders. This high incidence associated with an acceptable safety profile supports a prophylactic epicardial pacing strategy for the patients undergoing TVR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Service de Cardiologie, Hôpital Bichat Claude Bernard, AP-HP, Paris, France.
- Université de Paris Cité, Paris, France.
- Service de Chirurgie Cardiaque, Hôpital Bichat Claude Bernard, AP-HP, Paris, France.
- Service de Cardiologie, Hôpital Beaujon, AP-HP, Clichy, France.
ORCID-Profile: Baptiste Bazire, Marylou Para, Fabrice Extramiana, Vincent Algalarrondo
Zitieren
APA
Bazire, B., Para, M., Raffoul, R., Nataf, P., Cachier, A., Extramiana, F., Iung, B., & Algalarrondo, V. (2023). Prophylactic epicardial pacemaker implantation in tricuspid valve replacement. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezad344
Vancouver
Bazire B, Para M, Raffoul R, Nataf P, Cachier A, Extramiana F, et al. Prophylactic epicardial pacemaker implantation in tricuspid valve replacement. European Journal of Cardio-Thoracic Surgery. 2023. doi:10.1093/ejcts/ezad344
BibTeX
@article{Bazire2023,
author = {Bazire, Baptiste and Para, Marylou and Raffoul, Richard and Nataf, Patrick and Cachier, Agnès and Extramiana, Fabrice and Iung, Bernard and Algalarrondo, Vincent},
title = {Prophylactic epicardial pacemaker implantation in tricuspid valve replacement},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2023},
doi = {10.1093/ejcts/ezad344}
}
EUVIMED